Literature DB >> 24732594

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.

A Veronese1, F Pepe1, J Chiacchia2, S Pagotto1, P Lanuti3, S Veschi1, M Di Marco4, A D'Argenio2, I Innocenti5, B Vannata5, F Autore5, M Marchisio3, D Wernicke6, F Verginelli2, G Leone5, L Z Rassenti7, T J Kipps7, R Mariani-Costantini1, L Laurenti5, C M Croce8, R Visone1.   

Abstract

Deregulation of the miR-15a/16-1 cluster has a key role in the pathogenesis of chronic lymphocytic leukemia (CLL), a clinically heterogeneous disease with indolent and aggressive forms. The miR-15a/16-1 locus is located at 13q14, the most frequently deleted region in CLL. Starting from functional investigations of a rare SNP upstream the miR cluster, we identified a novel allele-specific mechanism that exploits a cryptic activator region to recruit the RNA polymerase III for miR-15a/16-1 transcription. This regulation of the miR-15a/16- locus is independent of the DLEU2 host gene, which is often transcribed monoallellically by RPII. We found that normally one allele of miR-15a/16-1 is transcribed by RNAPII, the other one by RNAPIII. In our subset of CLL patients harboring 13q14 deletions, exclusive RNA polymerase III (RPIII)-driven transcription of the miR-15a/16-1 was the consequence of loss of the RPII-regulated allele and correlated with high expression of the poor prognostic marker ZAP70 (P=0.019). Thus, our findings point to a novel biological process, characterized by double allele-specific transcriptional regulation of the miR-15a/16-1 locus by alternative mechanisms. Differential usage of these mechanisms may distinguish at onset aggressive from indolent forms of CLL. This provides a basis for the clinical heterogeneity of the CLL patients carrying 13q14 deletions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24732594      PMCID: PMC4198514          DOI: 10.1038/leu.2014.139

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  60 in total

1.  MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.

Authors:  A Stacchini; M Aragno; A Vallario; A Alfarano; P Circosta; D Gottardi; A Faldella; G Rege-Cambrin; U Thunberg; K Nilsson; F Caligaris-Cappio
Journal:  Leuk Res       Date:  1999-02       Impact factor: 3.156

Review 2.  Recruitment of RNA polymerase III to its target promoters.

Authors:  Laura Schramm; Nouria Hernandez
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

3.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

4.  Three human RNA polymerase III-specific subunits form a subcomplex with a selective function in specific transcription initiation.

Authors:  Z Wang; R G Roeder
Journal:  Genes Dev       Date:  1997-05-15       Impact factor: 11.361

Review 5.  Monoclonal B-cell lymphocytosis.

Authors:  Andy C Rawstron
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

6.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

7.  Karyotype-specific microRNA signature in chronic lymphocytic leukemia.

Authors:  Rosa Visone; Laura Z Rassenti; Angelo Veronese; Cristian Taccioli; Stefan Costinean; Baltazar D Aguda; Stefano Volinia; Manuela Ferracin; Jeff Palatini; Veronica Balatti; Hansjuerg Alder; Massimo Negrini; Thomas J Kipps; Carlo M Croce
Journal:  Blood       Date:  2009-08-28       Impact factor: 22.113

8.  High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.

Authors:  Jennifer Edelmann; Karlheinz Holzmann; Florian Miller; Dirk Winkler; Andreas Bühler; Thorsten Zenz; Lars Bullinger; Michael W M Kühn; Andreas Gerhardinger; Johannes Bloehdorn; Ina Radtke; Xiaoping Su; Jing Ma; Stanley Pounds; Michael Hallek; Peter Lichter; Jan Korbel; Raymonde Busch; Daniel Mertens; James R Downing; Stephan Stilgenbauer; Hartmut Döhner
Journal:  Blood       Date:  2012-10-09       Impact factor: 22.113

9.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

10.  Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs.

Authors:  Erika Varkonyi-Gasic; Rongmei Wu; Marion Wood; Eric F Walton; Roger P Hellens
Journal:  Plant Methods       Date:  2007-10-12       Impact factor: 4.993

View more
  15 in total

Review 1.  Chronic lymphocytic leukaemia.

Authors:  Thomas J Kipps; Freda K Stevenson; Catherine J Wu; Carlo M Croce; Graham Packham; William G Wierda; Susan O'Brien; John Gribben; Kanti Rai
Journal:  Nat Rev Dis Primers       Date:  2017-01-19       Impact factor: 52.329

2.  TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Authors:  Patricia K A Mongini; Rashmi Gupta; Erin Boyle; Jennifer Nieto; Hyunjoo Lee; Joanna Stein; Jela Bandovic; Tatjana Stankovic; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

3.  Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Authors:  G Cutrona; S Matis; M Colombo; C Massucco; G Baio; F Valdora; L Emionite; S Fabris; A G Recchia; M Gentile; C E Neumaier; D Reverberi; R Massara; S Boccardo; L Basso; S Salvi; F Rosa; M Cilli; S Zupo; M Truini; P Tassone; M Calabrese; M Negrini; A Neri; F Morabito; F Fais; M Ferrarini
Journal:  Leukemia       Date:  2017-01-05       Impact factor: 11.528

4.  Universal attenuators and their interactions with feedback loops in gene regulatory networks.

Authors:  Dianbo Liu; Luca Albergante; Timothy J Newman
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

5.  Novel mechanisms of regulation of miRNAs in CLL.

Authors:  Veronica Balatti; Mario Acunzo; Yuri Pekarky; Carlo M Croce
Journal:  Trends Cancer       Date:  2016-03

6.  MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.

Authors:  Nunu Huang; Jiangbin Wu; Wei Qiu; Qing Lyu; Jie He; Weidong Xie; Naihan Xu; Yaou Zhang
Journal:  Cancer Biol Ther       Date:  2015-05-06       Impact factor: 4.742

Review 7.  Role of microRNA in chronic lymphocytic leukemia onset and progression.

Authors:  Veronica Balatti; Yuri Pekarky; Carlo M Croce
Journal:  J Hematol Oncol       Date:  2015-02-20       Impact factor: 17.388

8.  Evolution of multiple cell clones over a 29-year period of a CLL patient.

Authors:  Zhikun Zhao; Lynn Goldin; Shiping Liu; Liang Wu; Weiyin Zhou; Hong Lou; Qichao Yu; Shirley X Tsang; Miaomiao Jiang; Fuqiang Li; MaryLou McMaster; Yang Li; Xinxin Lin; Zhifeng Wang; Liqin Xu; Gerald Marti; Guibo Li; Kui Wu; Meredith Yeager; Huanming Yang; Xun Xu; Stephen J Chanock; Bo Li; Yong Hou; Neil Caporaso; Michael Dean
Journal:  Nat Commun       Date:  2016-12-16       Impact factor: 14.919

9.  Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

Authors:  Apollinaire Ngankeu; Parvathi Ranganathan; Violaine Havelange; Deedra Nicolet; Stefano Volinia; Bayard L Powell; Jonathan E Kolitz; Geoffrey L Uy; Richard M Stone; Steven M Kornblau; Michael Andreeff; Carlo M Croce; Clara D Bloomfield; Ramiro Garzon
Journal:  Oncotarget       Date:  2017-12-12

Review 10.  Epigenetics and MicroRNAs in Cancer.

Authors:  Alice Ramassone; Sara Pagotto; Angelo Veronese; Rosa Visone
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.